

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | locomotory exploration behavior (GO:0035641) | 4.72050772 |
| 2 | synaptic vesicle maturation (GO:0016188) | 4.64722112 |
| 3 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 4.48980374 |
| 4 | mannose metabolic process (GO:0006013) | 4.12151453 |
| 5 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 4.10222506 |
| 6 | sodium ion export (GO:0071436) | 4.08582672 |
| 7 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 4.07696071 |
| 8 | negative regulation of erythrocyte differentiation (GO:0045647) | 4.07671850 |
| 9 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 4.01164487 |
| 10 | layer formation in cerebral cortex (GO:0021819) | 3.90492877 |
| 11 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.83364670 |
| 12 | cell communication by electrical coupling (GO:0010644) | 3.82598413 |
| 13 | negative regulation of fibrinolysis (GO:0051918) | 3.78725520 |
| 14 | vocalization behavior (GO:0071625) | 3.75542231 |
| 15 | cellular potassium ion homeostasis (GO:0030007) | 3.71971993 |
| 16 | regulation of synapse structural plasticity (GO:0051823) | 3.67470618 |
| 17 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 3.61846015 |
| 18 | glutamate secretion (GO:0014047) | 3.58416540 |
| 19 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 3.49483214 |
| 20 | activation of protein kinase A activity (GO:0034199) | 3.49211737 |
| 21 | synaptic vesicle exocytosis (GO:0016079) | 3.48153048 |
| 22 | regulation of synaptic vesicle exocytosis (GO:2000300) | 3.38342066 |
| 23 | regulation of glutamate receptor signaling pathway (GO:1900449) | 3.36459739 |
| 24 | regulation of ARF protein signal transduction (GO:0032012) | 3.36302817 |
| 25 | gamma-aminobutyric acid transport (GO:0015812) | 3.33215691 |
| 26 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 3.31796079 |
| 27 | cell communication involved in cardiac conduction (GO:0086065) | 3.31639201 |
| 28 | neurotransmitter secretion (GO:0007269) | 3.30093079 |
| 29 | potassium ion import (GO:0010107) | 3.29930167 |
| 30 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.27178073 |
| 31 | negative regulation of cell killing (GO:0031342) | 3.27178073 |
| 32 | exploration behavior (GO:0035640) | 3.26274366 |
| 33 | peptidyl-glutamic acid carboxylation (GO:0017187) | 3.25725677 |
| 34 | protein carboxylation (GO:0018214) | 3.25725677 |
| 35 | cerebellar Purkinje cell differentiation (GO:0021702) | 3.23869077 |
| 36 | regulation of fibrinolysis (GO:0051917) | 3.17919143 |
| 37 | complement activation, alternative pathway (GO:0006957) | 3.16938607 |
| 38 | establishment of nucleus localization (GO:0040023) | 3.12295321 |
| 39 | plasma membrane repair (GO:0001778) | 3.09697189 |
| 40 | membrane depolarization during action potential (GO:0086010) | 3.08892873 |
| 41 | neuronal action potential propagation (GO:0019227) | 3.08852592 |
| 42 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 3.08473314 |
| 43 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 3.06498978 |
| 44 | neurotransmitter-gated ion channel clustering (GO:0072578) | 3.06358791 |
| 45 | regulation of neuronal synaptic plasticity (GO:0048168) | 3.05635442 |
| 46 | regulation of synaptic vesicle transport (GO:1902803) | 3.03961437 |
| 47 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 3.01720174 |
| 48 | dendrite morphogenesis (GO:0048813) | 3.00490782 |
| 49 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 2.98734535 |
| 50 | protein-lipid complex assembly (GO:0065005) | 2.98357113 |
| 51 | regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) | 2.97905983 |
| 52 | regulation of apoptotic cell clearance (GO:2000425) | 2.96519217 |
| 53 | neuromuscular process controlling balance (GO:0050885) | 2.94750224 |
| 54 | positive regulation of synapse maturation (GO:0090129) | 2.94667985 |
| 55 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 2.94475531 |
| 56 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 2.92209892 |
| 57 | response to pheromone (GO:0019236) | 2.92199764 |
| 58 | dendritic spine morphogenesis (GO:0060997) | 2.92169533 |
| 59 | positive regulation of gamma-delta T cell activation (GO:0046645) | 2.91049643 |
| 60 | regulation of ARF GTPase activity (GO:0032312) | 2.90096381 |
| 61 | protein localization to synapse (GO:0035418) | 2.89469105 |
| 62 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 2.89405711 |
| 63 | dicarboxylic acid biosynthetic process (GO:0043650) | 2.87874494 |
| 64 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 2.87552932 |
| 65 | proline transport (GO:0015824) | 2.87237658 |
| 66 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 2.87089708 |
| 67 | regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314) | 2.83959036 |
| 68 | plasma lipoprotein particle assembly (GO:0034377) | 2.83586760 |
| 69 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 2.83546135 |
| 70 | cellular sodium ion homeostasis (GO:0006883) | 2.83351479 |
| 71 | negative regulation of cell size (GO:0045792) | 2.82482399 |
| 72 | regulation of cholesterol homeostasis (GO:2000188) | 2.80404143 |
| 73 | positive regulation of lipoprotein lipase activity (GO:0051006) | 2.79426543 |
| 74 | positive regulation of triglyceride lipase activity (GO:0061365) | 2.79426543 |
| 75 | protein localization to endosome (GO:0036010) | 2.78913945 |
| 76 | negative regulation of potassium ion transmembrane transport (GO:1901380) | 2.78269288 |
| 77 | regulation of membrane repolarization (GO:0060306) | 2.77834975 |
| 78 | regulation of extracellular matrix disassembly (GO:0010715) | 2.77582620 |
| 79 | regulation of protein activation cascade (GO:2000257) | 2.77147505 |
| 80 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 2.76896526 |
| 81 | phospholipid efflux (GO:0033700) | 2.76566090 |
| 82 | long-term memory (GO:0007616) | 2.76490001 |
| 83 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 2.74070342 |
| 84 | antigen processing and presentation of endogenous antigen (GO:0019883) | 2.73960541 |
| 85 | cerebellar granule cell differentiation (GO:0021707) | 2.73258240 |
| 86 | positive regulation of potassium ion transmembrane transport (GO:1901381) | 2.72830802 |
| 87 | synaptic transmission, glutamatergic (GO:0035249) | 2.70557353 |
| 88 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 2.70344575 |
| 89 | positive regulation of extracellular matrix organization (GO:1903055) | 2.68920368 |
| 90 | alanine transport (GO:0032328) | 2.68186629 |
| 91 | regulation of complement activation (GO:0030449) | 2.67788530 |
| 92 | glycine transport (GO:0015816) | 2.66732757 |
| 93 | positive thymic T cell selection (GO:0045059) | 2.66462614 |
| 94 | regulation of calcium ion transmembrane transporter activity (GO:1901019) | 2.63989928 |
| 95 | regulation of calcium ion transmembrane transport (GO:1903169) | 2.63989928 |
| 96 | positive regulation of calcium ion transmembrane transporter activity (GO:1901021) | 2.63067582 |
| 97 | response to muramyl dipeptide (GO:0032495) | 2.63057219 |
| 98 | regulation of dendritic spine morphogenesis (GO:0061001) | 2.62779638 |
| 99 | glutamate receptor signaling pathway (GO:0007215) | 2.62747847 |
| 100 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 2.62294521 |
| 101 | cerebellar Purkinje cell layer development (GO:0021680) | 2.59247961 |
| 102 | prepulse inhibition (GO:0060134) | 2.58233982 |
| 103 | regulation of cholesterol esterification (GO:0010872) | 2.57329249 |
| 104 | neuromuscular process controlling posture (GO:0050884) | 2.56203187 |
| 105 | cardiac muscle contraction (GO:0060048) | 2.55619249 |
| 106 | potassium ion homeostasis (GO:0055075) | 2.54314633 |
| 107 | barbed-end actin filament capping (GO:0051016) | 2.53212860 |
| 108 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 2.52896851 |
| 109 | membrane repolarization (GO:0086009) | 2.52546671 |
| 110 | response to laminar fluid shear stress (GO:0034616) | 2.51538553 |
| 111 | detection of bacterium (GO:0016045) | 2.50820989 |
| 112 | negative regulation of fatty acid transport (GO:2000192) | 2.49943215 |
| 113 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 2.49782191 |
| 114 | urea metabolic process (GO:0019627) | 2.49659128 |
| 115 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 2.49419305 |
| 116 | positive regulation of Rap GTPase activity (GO:0032854) | 2.48816603 |
| 117 | regulation of postsynaptic membrane potential (GO:0060078) | 2.48725991 |
| 118 | carnitine shuttle (GO:0006853) | 2.48449971 |
| 119 | regulation of extracellular matrix organization (GO:1903053) | 2.47420576 |
| 120 | detection of other organism (GO:0098543) | 2.47420226 |
| 121 | very-low-density lipoprotein particle assembly (GO:0034379) | 2.47008501 |
| 122 | cholesterol efflux (GO:0033344) | 2.46008614 |
| 123 | urea cycle (GO:0000050) | 2.45834899 |
| 124 | neurotransmitter transport (GO:0006836) | 2.45135650 |
| 125 | neuron-neuron synaptic transmission (GO:0007270) | 2.44580603 |
| 126 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 2.44214301 |
| 127 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 2.44140758 |
| 128 | modulation by symbiont of host immune response (GO:0052553) | 2.44140758 |
| 129 | positive regulation by symbiont of host defense response (GO:0052509) | 2.44140758 |
| 130 | modulation by symbiont of host defense response (GO:0052031) | 2.44140758 |
| 131 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.44140758 |
| 132 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 2.44140758 |
| 133 | negative regulation of cholesterol transport (GO:0032375) | 2.44090888 |
| 134 | negative regulation of sterol transport (GO:0032372) | 2.44090888 |
| 135 | regulation of cholesterol biosynthetic process (GO:0045540) | 2.43735442 |
| 136 | signal complex assembly (GO:0007172) | 2.43111285 |
| 137 | thymic T cell selection (GO:0045061) | 2.42794966 |
| 138 | cardiac myofibril assembly (GO:0055003) | 2.42608435 |
| 139 | nitrogen cycle metabolic process (GO:0071941) | 2.42540415 |
| 140 | synaptic vesicle endocytosis (GO:0048488) | 2.42372002 |
| 141 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 2.42012643 |
| 142 | positive regulation of membrane potential (GO:0045838) | 2.41482682 |
| 143 | regulation of cholesterol metabolic process (GO:0090181) | 2.41398065 |
| 144 | membrane depolarization (GO:0051899) | 2.41221160 |
| 145 | cell migration in hindbrain (GO:0021535) | 2.40750818 |
| 146 | positive regulation of sodium ion transport (GO:0010765) | 2.40406722 |
| 147 | positive regulation of phagocytosis (GO:0050766) | 2.39577878 |
| 148 | acute-phase response (GO:0006953) | 2.39514860 |
| 149 | regulation of monocyte differentiation (GO:0045655) | 2.39350988 |
| 150 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.39314526 |
| 151 | membrane repolarization during cardiac muscle cell action potential (GO:0086013) | 2.39192741 |
| 152 | vesicle transport along microtubule (GO:0047496) | 2.39086597 |
| 153 | protein targeting to Golgi (GO:0000042) | 2.38381178 |
| 154 | regulation of glucose import in response to insulin stimulus (GO:2001273) | 2.38320169 |
| 155 | nerve growth factor signaling pathway (GO:0038180) | 2.38261798 |
| 156 | macrophage activation involved in immune response (GO:0002281) | 2.38103760 |
| 157 | protein-lipid complex subunit organization (GO:0071825) | 2.38022447 |
| 158 | regulation of neurotransmitter levels (GO:0001505) | 2.37108482 |
| 159 | regulation of ion transmembrane transporter activity (GO:0032412) | 2.35698850 |
| 160 | cell differentiation in hindbrain (GO:0021533) | 2.35073723 |
| 161 | positive regulation of potassium ion transport (GO:0043268) | 2.34653834 |
| 162 | regulation of synaptic plasticity (GO:0048167) | 2.34553542 |
| 163 | positive regulation of synaptic transmission, glutamatergic (GO:0051968) | 2.34268821 |
| 164 | cell-cell junction maintenance (GO:0045217) | 2.32316848 |
| 165 | activation of JUN kinase activity (GO:0007257) | 2.31556088 |
| 166 | detection of external biotic stimulus (GO:0098581) | 2.30237649 |
| 167 | regulation of early endosome to late endosome transport (GO:2000641) | 2.30024238 |
| 168 | regulation of gamma-delta T cell activation (GO:0046643) | 2.30000863 |
| 169 | protein-lipid complex remodeling (GO:0034368) | 2.29378849 |
| 170 | macromolecular complex remodeling (GO:0034367) | 2.29378849 |
| 171 | plasma lipoprotein particle remodeling (GO:0034369) | 2.29378849 |
| 172 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.28526575 |
| 173 | pinocytosis (GO:0006907) | 2.27254081 |
| 174 | focal adhesion assembly (GO:0048041) | 2.27249297 |
| 175 | cell-substrate adherens junction assembly (GO:0007045) | 2.27249297 |
| 176 | regulation of fatty acid biosynthetic process (GO:0042304) | 2.26640524 |
| 177 | plasma lipoprotein particle organization (GO:0071827) | 2.26506480 |
| 178 | adherens junction assembly (GO:0034333) | 2.26370270 |
| 179 | negative regulation of myotube differentiation (GO:0010832) | 2.26186986 |
| 180 | germinal center formation (GO:0002467) | 2.25706751 |
| 181 | modulation by symbiont of host cellular process (GO:0044068) | 2.25160659 |
| 182 | negative regulation of lipid transport (GO:0032369) | 2.24905099 |
| 183 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 2.24270719 |
| 184 | NIK/NF-kappaB signaling (GO:0038061) | 2.24154949 |
| 185 | plasma lipoprotein particle clearance (GO:0034381) | 2.22469870 |
| 186 | regulation of gamma-delta T cell differentiation (GO:0045586) | 2.22333271 |
| 187 | low-density lipoprotein particle remodeling (GO:0034374) | 2.21738518 |
| 188 | positive regulation of fatty acid biosynthetic process (GO:0045723) | 2.20782529 |
| 189 | regulation of leukocyte degranulation (GO:0043300) | 2.20462952 |
| 190 | activation of MAPKKK activity (GO:0000185) | 2.18809774 |
| 191 | creatine metabolic process (GO:0006600) | 2.17611967 |
| 192 | negative regulation of toll-like receptor signaling pathway (GO:0034122) | 2.16968839 |
| 193 | negative regulation of granulocyte differentiation (GO:0030853) | 2.15709784 |
| 194 | diacylglycerol metabolic process (GO:0046339) | 2.15236463 |
| 195 | regulation of phagocytosis (GO:0050764) | 2.15165136 |
| 196 | detection of molecule of bacterial origin (GO:0032490) | 2.14982199 |
| 197 | regulation of NFAT protein import into nucleus (GO:0051532) | 2.14608503 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 4.21417948 |
| 2 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.86439594 |
| 3 | * DROSHA_22980978_ChIP-Seq_HELA_Human | 2.63772343 |
| 4 | MYC_22102868_ChIP-Seq_BL_Human | 2.52633101 |
| 5 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 2.43399168 |
| 6 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 2.35414914 |
| 7 | * EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 2.33617414 |
| 8 | TCF7_22412390_ChIP-Seq_EML_Mouse | 2.31593898 |
| 9 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.30592529 |
| 10 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.25722305 |
| 11 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 2.25630427 |
| 12 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.17110571 |
| 13 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.16155275 |
| 14 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 2.10608635 |
| 15 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.09675292 |
| 16 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.08992518 |
| 17 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.08992518 |
| 18 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.05432522 |
| 19 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.01997139 |
| 20 | REST_21632747_ChIP-Seq_MESCs_Mouse | 2.01173000 |
| 21 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.98102916 |
| 22 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.95834455 |
| 23 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.87432158 |
| 24 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.86509032 |
| 25 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.84221636 |
| 26 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.81085485 |
| 27 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.77908466 |
| 28 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.77666168 |
| 29 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.76322618 |
| 30 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.75336097 |
| 31 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.72840172 |
| 32 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.71601910 |
| 33 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.71050751 |
| 34 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.69388323 |
| 35 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.68821436 |
| 36 | P68_20966046_ChIP-Seq_HELA_Human | 1.67196457 |
| 37 | KDM2B_26808549_Chip-Seq_K562_Human | 1.65879333 |
| 38 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.65709071 |
| 39 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.63768641 |
| 40 | MAF_26560356_Chip-Seq_TH1_Human | 1.61750661 |
| 41 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.52838673 |
| 42 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.52525394 |
| 43 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.52174200 |
| 44 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.49927894 |
| 45 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.49772399 |
| 46 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.49253545 |
| 47 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.49148855 |
| 48 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.48271016 |
| 49 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.48115414 |
| 50 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.48051204 |
| 51 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.46775741 |
| 52 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.46571838 |
| 53 | UTX_26944678_Chip-Seq_JUKART_Human | 1.46082044 |
| 54 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.44872359 |
| 55 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.42233802 |
| 56 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.41898748 |
| 57 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.41851044 |
| 58 | MAF_26560356_Chip-Seq_TH2_Human | 1.39893833 |
| 59 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.39399420 |
| 60 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.39215750 |
| 61 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.39100461 |
| 62 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.38502594 |
| 63 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.38271892 |
| 64 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.38252140 |
| 65 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.36810017 |
| 66 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.36656058 |
| 67 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.36205711 |
| 68 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.35797715 |
| 69 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.35708267 |
| 70 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.34862929 |
| 71 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.33325232 |
| 72 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.33071983 |
| 73 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.31341086 |
| 74 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.30253479 |
| 75 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.28825724 |
| 76 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.28655985 |
| 77 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.28588188 |
| 78 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.26913369 |
| 79 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.26456574 |
| 80 | SPI1_23127762_ChIP-Seq_K562_Human | 1.25973744 |
| 81 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.25274883 |
| 82 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.24107633 |
| 83 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.23788548 |
| 84 | AR_19668381_ChIP-Seq_PC3_Human | 1.23413933 |
| 85 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.22537225 |
| 86 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.22418280 |
| 87 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.22344102 |
| 88 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.21194364 |
| 89 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.20489641 |
| 90 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.20432260 |
| 91 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.20255397 |
| 92 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.19824067 |
| 93 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 1.18961922 |
| 94 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.18594517 |
| 95 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.18549650 |
| 96 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.18397198 |
| 97 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.17264336 |
| 98 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.17106331 |
| 99 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.16874244 |
| 100 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.16567052 |
| 101 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.16344570 |
| 102 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.15961958 |
| 103 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.15856516 |
| 104 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.15662161 |
| 105 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.14860273 |
| 106 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.13758927 |
| 107 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.12712683 |
| 108 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.12700638 |
| 109 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.12685098 |
| 110 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.11623951 |
| 111 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.11622093 |
| 112 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.10838259 |
| 113 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.10831958 |
| 114 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.10281534 |
| 115 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.08942223 |
| 116 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 1.08925952 |
| 117 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 1.08074028 |
| 118 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.07954192 |
| 119 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.07678175 |
| 120 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.07203197 |
| 121 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.06956830 |
| 122 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.06842536 |
| 123 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.06289210 |
| 124 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.06058051 |
| 125 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.05361456 |
| 126 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.05045336 |
| 127 | MYCN_27167114_Chip-Seq_NEUROBLASTOMA_Human | 1.03577697 |
| 128 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 1.03470275 |
| 129 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.02814860 |
| 130 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.02417588 |
| 131 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.02150679 |
| 132 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.01853545 |
| 133 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.01853545 |
| 134 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.01744765 |
| 135 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.01628877 |
| 136 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 1.01332175 |
| 137 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.01252486 |
| 138 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 1.00363392 |
| 139 | TP63_22573176_ChIP-Seq_HFKS_Human | 1.00290904 |
| 140 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.99790595 |
| 141 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.99556434 |
| 142 | GATA1_19941826_ChIP-Seq_K562_Human | 0.99532471 |
| 143 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 0.99473973 |
| 144 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 0.98910702 |
| 145 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 0.98581492 |
| 146 | TP53_22127205_ChIP-Seq_IMR90_Human | 0.96286244 |
| 147 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.95609513 |
| 148 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 0.94759995 |
| 149 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.94523495 |
| 150 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 0.93556868 |
| 151 | TP53_16413492_ChIP-PET_HCT116_Human | 0.92626801 |
| 152 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 0.92464662 |
| 153 | CREB1_26743006_Chip-Seq_LNCaP_Human | 0.90439852 |
| 154 | STAT3_23295773_ChIP-Seq_U87_Human | 0.90436395 |
| 155 | TET1_21490601_ChIP-Seq_MESCs_Mouse | 0.90109278 |
| 156 | KLF4_19829295_ChIP-Seq_ESCs_Human | 0.90101446 |
| 157 | SMC4_20622854_ChIP-Seq_HELA_Human | 0.88922641 |
| 158 | TFAP2A_17053090_ChIP-ChIP_MCF-7_Human | 0.88243191 |
| 159 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 0.88131170 |
| 160 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 0.86374126 |
| 161 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 0.85804245 |
| 162 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.85790992 |
| 163 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 0.83264392 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004859_abnormal_synaptic_plasticity | 5.72147110 |
| 2 | MP0005451_abnormal_body_composition | 3.46386856 |
| 3 | MP0005058_abnormal_lysosome_morphology | 3.41671077 |
| 4 | MP0003635_abnormal_synaptic_transmissio | 3.21928600 |
| 5 | MP0002837_dystrophic_cardiac_calcinosis | 3.14842168 |
| 6 | MP0003436_decreased_susceptibility_to | 3.10086654 |
| 7 | MP0003172_abnormal_lysosome_physiology | 3.00745656 |
| 8 | MP0003303_peritoneal_inflammation | 2.97977509 |
| 9 | MP0004270_analgesia | 2.93325779 |
| 10 | MP0000751_myopathy | 2.69068230 |
| 11 | MP0009840_abnormal_foam_cell | 2.54321212 |
| 12 | MP0008260_abnormal_autophagy | 2.51083591 |
| 13 | MP0003646_muscle_fatigue | 2.49852085 |
| 14 | MP0002063_abnormal_learning/memory/cond | 2.45394177 |
| 15 | MP0009046_muscle_twitch | 2.45310576 |
| 16 | MP0009780_abnormal_chondrocyte_physiolo | 2.39122446 |
| 17 | MP0009745_abnormal_behavioral_response | 2.34757289 |
| 18 | MP0002909_abnormal_adrenal_gland | 2.31680110 |
| 19 | MP0002822_catalepsy | 2.28842177 |
| 20 | MP0002064_seizures | 2.25902264 |
| 21 | MP0003191_abnormal_cellular_cholesterol | 2.24816634 |
| 22 | MP0004130_abnormal_muscle_cell | 2.23933738 |
| 23 | MP0003300_gastrointestinal_ulcer | 2.21992322 |
| 24 | MP0004145_abnormal_muscle_electrophysio | 2.09547244 |
| 25 | MP0004215_abnormal_myocardial_fiber | 2.07258423 |
| 26 | MP0003880_abnormal_central_pattern | 2.04292321 |
| 27 | MP0008569_lethality_at_weaning | 2.02109649 |
| 28 | MP0009278_abnormal_bone_marrow | 1.95419777 |
| 29 | MP0003329_amyloid_beta_deposits | 1.84669620 |
| 30 | MP0004084_abnormal_cardiac_muscle | 1.83597692 |
| 31 | MP0002572_abnormal_emotion/affect_behav | 1.79360417 |
| 32 | MP0004036_abnormal_muscle_relaxation | 1.79191273 |
| 33 | MP0005409_darkened_coat_color | 1.77511700 |
| 34 | MP0004858_abnormal_nervous_system | 1.77010254 |
| 35 | MP0005076_abnormal_cell_differentiation | 1.76742995 |
| 36 | MP0008961_abnormal_basal_metabolism | 1.75784283 |
| 37 | MP0005423_abnormal_somatic_nervous | 1.75565167 |
| 38 | MP0001968_abnormal_touch/_nociception | 1.75359181 |
| 39 | MP0002734_abnormal_mechanical_nocicepti | 1.74515389 |
| 40 | MP0002272_abnormal_nervous_system | 1.74357615 |
| 41 | MP0001849_ear_inflammation | 1.74110830 |
| 42 | MP0000685_abnormal_immune_system | 1.66170801 |
| 43 | MP0000569_abnormal_digit_pigmentation | 1.65122795 |
| 44 | MP0001486_abnormal_startle_reflex | 1.60063981 |
| 45 | MP0002419_abnormal_innate_immunity | 1.59636292 |
| 46 | MP0005025_abnormal_response_to | 1.59238194 |
| 47 | MP0004087_abnormal_muscle_fiber | 1.54151499 |
| 48 | MP0004233_abnormal_muscle_weight | 1.50896992 |
| 49 | MP0000749_muscle_degeneration | 1.49404003 |
| 50 | MP0004811_abnormal_neuron_physiology | 1.49382988 |
| 51 | MP0004947_skin_inflammation | 1.49342851 |
| 52 | MP0001440_abnormal_grooming_behavior | 1.48311965 |
| 53 | MP0005464_abnormal_platelet_physiology | 1.44773410 |
| 54 | MP0003137_abnormal_impulse_conducting | 1.44603485 |
| 55 | MP0005387_immune_system_phenotype | 1.43393291 |
| 56 | MP0001790_abnormal_immune_system | 1.43393291 |
| 57 | MP0003283_abnormal_digestive_organ | 1.42407337 |
| 58 | MP0003091_abnormal_cell_migration | 1.42113531 |
| 59 | MP0005360_urolithiasis | 1.41574098 |
| 60 | MP0002067_abnormal_sensory_capabilities | 1.41551099 |
| 61 | MP0004185_abnormal_adipocyte_glucose | 1.41457669 |
| 62 | MP0002139_abnormal_hepatobiliary_system | 1.40197065 |
| 63 | MP0001533_abnormal_skeleton_physiology | 1.38917087 |
| 64 | MP0000858_altered_metastatic_potential | 1.38311524 |
| 65 | MP0002269_muscular_atrophy | 1.38234779 |
| 66 | MP0005386_behavior/neurological_phenoty | 1.36786087 |
| 67 | MP0004924_abnormal_behavior | 1.36786087 |
| 68 | MP0002735_abnormal_chemical_nociception | 1.36627767 |
| 69 | MP0004885_abnormal_endolymph | 1.34637165 |
| 70 | MP0003633_abnormal_nervous_system | 1.34327354 |
| 71 | MP0000747_muscle_weakness | 1.34254158 |
| 72 | MP0003705_abnormal_hypodermis_morpholog | 1.33423569 |
| 73 | MP0004085_abnormal_heartbeat | 1.32326340 |
| 74 | MP0000013_abnormal_adipose_tissue | 1.31846635 |
| 75 | MP0001501_abnormal_sleep_pattern | 1.31606983 |
| 76 | MP0002733_abnormal_thermal_nociception | 1.30689977 |
| 77 | MP0005000_abnormal_immune_tolerance | 1.30002833 |
| 78 | MP0002089_abnormal_postnatal_growth/wei | 1.28621398 |
| 79 | MP0005620_abnormal_muscle_contractility | 1.28564633 |
| 80 | MP0003183_abnormal_peptide_metabolism | 1.28483447 |
| 81 | MP0005330_cardiomyopathy | 1.28350617 |
| 82 | MP0003763_abnormal_thymus_physiology | 1.27155597 |
| 83 | MP0005085_abnormal_gallbladder_physiolo | 1.23701992 |
| 84 | MP0003690_abnormal_glial_cell | 1.23427879 |
| 85 | MP0000955_abnormal_spinal_cord | 1.23364515 |
| 86 | MP0003724_increased_susceptibility_to | 1.22924571 |
| 87 | MP0005365_abnormal_bile_salt | 1.22637722 |
| 88 | MP0002933_joint_inflammation | 1.22347147 |
| 89 | MP0000778_abnormal_nervous_system | 1.22039477 |
| 90 | MP0002998_abnormal_bone_remodeling | 1.21923161 |
| 91 | MP0002184_abnormal_innervation | 1.21496391 |
| 92 | MP0001800_abnormal_humoral_immune | 1.21132291 |
| 93 | MP0001958_emphysema | 1.20904080 |
| 94 | MP0003252_abnormal_bile_duct | 1.19488896 |
| 95 | MP0003566_abnormal_cell_adhesion | 1.19384534 |
| 96 | MP0001835_abnormal_antigen_presentation | 1.19182669 |
| 97 | MP0004510_myositis | 1.19021413 |
| 98 | MP0001970_abnormal_pain_threshold | 1.17554247 |
| 99 | MP0005375_adipose_tissue_phenotype | 1.17250477 |
| 100 | MP0003453_abnormal_keratinocyte_physiol | 1.17234200 |
| 101 | MP0002557_abnormal_social/conspecific_i | 1.16112635 |
| 102 | MP0010329_abnormal_lipoprotein_level | 1.14960230 |
| 103 | MP0002972_abnormal_cardiac_muscle | 1.14801429 |
| 104 | MP0002736_abnormal_nociception_after | 1.12973709 |
| 105 | MP0002723_abnormal_immune_serum | 1.12215851 |
| 106 | MP0010155_abnormal_intestine_physiology | 1.12141191 |
| 107 | MP0003279_aneurysm | 1.10830181 |
| 108 | MP0003045_fibrosis | 1.10741462 |
| 109 | MP0008438_abnormal_cutaneous_collagen | 1.10429478 |
| 110 | MP0002066_abnormal_motor_capabilities/c | 1.10426535 |
| 111 | MP0002138_abnormal_hepatobiliary_system | 1.09912343 |
| 112 | MP0005083_abnormal_biliary_tract | 1.08551340 |
| 113 | MP0000759_abnormal_skeletal_muscle | 1.07234748 |
| 114 | MP0003879_abnormal_hair_cell | 1.06888023 |
| 115 | MP0003631_nervous_system_phenotype | 1.06344572 |
| 116 | MP0005187_abnormal_penis_morphology | 1.05751526 |
| 117 | MP0001348_abnormal_lacrimal_gland | 1.05027793 |
| 118 | MP0002420_abnormal_adaptive_immunity | 1.04839280 |
| 119 | MP0002249_abnormal_larynx_morphology | 1.04377073 |
| 120 | MP0000920_abnormal_myelination | 1.04197243 |
| 121 | MP0002971_abnormal_brown_adipose | 1.03471123 |
| 122 | MP0001819_abnormal_immune_cell | 1.03242424 |
| 123 | MP0002106_abnormal_muscle_physiology | 1.02639720 |
| 124 | MP0009333_abnormal_splenocyte_physiolog | 1.02190167 |
| 125 | MP0005535_abnormal_body_temperature | 1.01228243 |
| 126 | MP0004484_altered_response_of | 1.01127057 |
| 127 | MP0000604_amyloidosis | 1.00578645 |
| 128 | MP0002882_abnormal_neuron_morphology | 1.00077912 |
| 129 | MP0000609_abnormal_liver_physiology | 0.99894982 |
| 130 | MP0008775_abnormal_heart_ventricle | 0.98861714 |
| 131 | MP0000678_abnormal_parathyroid_gland | 0.98164015 |
| 132 | MP0006082_CNS_inflammation | 0.96350877 |
| 133 | MP0002452_abnormal_antigen_presenting | 0.94978437 |
| 134 | MP0001915_intracranial_hemorrhage | 0.93334139 |
| 135 | MP0008469_abnormal_protein_level | 0.92410710 |
| 136 | MP0008874_decreased_physiological_sensi | 0.92214136 |
| 137 | MP0003634_abnormal_glial_cell | 0.91917643 |
| 138 | MP0004043_abnormal_pH_regulation | 0.91066146 |
| 139 | MP0002405_respiratory_system_inflammati | 0.90704331 |
| 140 | MP0005166_decreased_susceptibility_to | 0.90213790 |
| 141 | MP0009785_altered_susceptibility_to | 0.89902524 |
| 142 | MP0001502_abnormal_circadian_rhythm | 0.89316329 |
| 143 | MP0005397_hematopoietic_system_phenotyp | 0.86297659 |
| 144 | MP0001545_abnormal_hematopoietic_system | 0.86297659 |
| 145 | MP0005369_muscle_phenotype | 0.86230986 |
| 146 | MP0002090_abnormal_vision | 0.85522972 |
| 147 | MP0010630_abnormal_cardiac_muscle | 0.85440950 |
| 148 | MP0005666_abnormal_adipose_tissue | 0.84189825 |
| 149 | MP0003828_pulmonary_edema | 0.84050554 |
| 150 | MP0000716_abnormal_immune_system | 0.83906481 |
| 151 | MP0002152_abnormal_brain_morphology | 0.83067103 |
| 152 | MP0000733_abnormal_muscle_development | 0.82203534 |
| 153 | MP0003656_abnormal_erythrocyte_physiolo | 0.81891115 |
| 154 | MP0001299_abnormal_eye_distance/ | 0.80990132 |
| 155 | MP0003075_altered_response_to | 0.80974481 |
| 156 | MP0000767_abnormal_smooth_muscle | 0.80851834 |
| 157 | MP0005385_cardiovascular_system_phenoty | 0.80650671 |
| 158 | MP0001544_abnormal_cardiovascular_syste | 0.80650671 |
| 159 | MP0010234_abnormal_vibrissa_follicle | 0.80548373 |
| 160 | MP0002229_neurodegeneration | 0.80350377 |
| 161 | MP0006138_congestive_heart_failure | 0.79894755 |
| 162 | MP0002234_abnormal_pharynx_morphology | 0.79776596 |
| 163 | MP0005671_abnormal_response_to | 0.79487547 |
| 164 | MP0002398_abnormal_bone_marrow | 0.79284144 |
| 165 | MP0002078_abnormal_glucose_homeostasis | 0.78934781 |
| 166 | MP0002118_abnormal_lipid_homeostasis | 0.78785158 |
| 167 | MP0000003_abnormal_adipose_tissue | 0.78685844 |
| 168 | MP0001845_abnormal_inflammatory_respons | 0.77579728 |
| 169 | MP0001851_eye_inflammation | 0.77519166 |
| 170 | MP0002069_abnormal_eating/drinking_beha | 0.77343754 |
| 171 | MP0003866_abnormal_defecation | 0.74599683 |
| 172 | MP0005023_abnormal_wound_healing | 0.72590578 |
| 173 | MP0005257_abnormal_intraocular_pressure | 0.70389545 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Myokymia (HP:0002411) | 4.30121808 |
| 2 | Focal motor seizures (HP:0011153) | 3.82273903 |
| 3 | Exercise-induced myalgia (HP:0003738) | 3.69991972 |
| 4 | Action tremor (HP:0002345) | 3.68519745 |
| 5 | Focal seizures (HP:0007359) | 3.67455166 |
| 6 | Visual hallucinations (HP:0002367) | 3.61844826 |
| 7 | Dysmetric saccades (HP:0000641) | 3.57011148 |
| 8 | Sudden death (HP:0001699) | 3.47343391 |
| 9 | Complement deficiency (HP:0004431) | 3.41580818 |
| 10 | Systemic lupus erythematosus (HP:0002725) | 3.39499557 |
| 11 | Bundle branch block (HP:0011710) | 3.35033345 |
| 12 | Eczematoid dermatitis (HP:0000976) | 3.31153220 |
| 13 | Abnormality of complement system (HP:0005339) | 3.18671023 |
| 14 | Abnormality of the lower motor neuron (HP:0002366) | 3.12874604 |
| 15 | Hemorrhage of the eye (HP:0011885) | 3.06192689 |
| 16 | Obstructive sleep apnea (HP:0002870) | 3.01000663 |
| 17 | Ventricular fibrillation (HP:0001663) | 3.00067566 |
| 18 | Cerebral aneurysm (HP:0004944) | 2.96306703 |
| 19 | Impaired social interactions (HP:0000735) | 2.95631861 |
| 20 | Abnormal social behavior (HP:0012433) | 2.95631861 |
| 21 | Progressive cerebellar ataxia (HP:0002073) | 2.95163648 |
| 22 | Joint hemorrhage (HP:0005261) | 2.88437965 |
| 23 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.88266724 |
| 24 | Difficulty running (HP:0009046) | 2.88100399 |
| 25 | Poor eye contact (HP:0000817) | 2.85174896 |
| 26 | Impaired vibration sensation in the lower limbs (HP:0002166) | 2.80577748 |
| 27 | Exercise-induced muscle cramps (HP:0003710) | 2.78166108 |
| 28 | Hyporeflexia of lower limbs (HP:0002600) | 2.76184523 |
| 29 | Supranuclear gaze palsy (HP:0000605) | 2.74595130 |
| 30 | Dysdiadochokinesis (HP:0002075) | 2.73902973 |
| 31 | Depression (HP:0000716) | 2.70287887 |
| 32 | Glomerulonephritis (HP:0000099) | 2.67571456 |
| 33 | Postural instability (HP:0002172) | 2.66908573 |
| 34 | Protrusio acetabuli (HP:0003179) | 2.63096868 |
| 35 | Hemiplegia (HP:0002301) | 2.62243128 |
| 36 | Ankle clonus (HP:0011448) | 2.58582428 |
| 37 | Dysostosis multiplex (HP:0000943) | 2.55640596 |
| 38 | Urinary bladder sphincter dysfunction (HP:0002839) | 2.50506195 |
| 39 | Neurofibrillary tangles (HP:0002185) | 2.49420876 |
| 40 | Intention tremor (HP:0002080) | 2.47936035 |
| 41 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 2.46950286 |
| 42 | Truncal ataxia (HP:0002078) | 2.45017131 |
| 43 | Syncope (HP:0001279) | 2.44734078 |
| 44 | Prolonged QT interval (HP:0001657) | 2.42403188 |
| 45 | Myoglobinuria (HP:0002913) | 2.41940271 |
| 46 | Urinary urgency (HP:0000012) | 2.41197161 |
| 47 | Insomnia (HP:0100785) | 2.41180931 |
| 48 | Generalized tonic-clonic seizures (HP:0002069) | 2.40798318 |
| 49 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 2.40612197 |
| 50 | Mucopolysacchariduria (HP:0008155) | 2.40023806 |
| 51 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.40023806 |
| 52 | Xanthomatosis (HP:0000991) | 2.39720929 |
| 53 | Epileptic encephalopathy (HP:0200134) | 2.37502425 |
| 54 | Calf muscle hypertrophy (HP:0008981) | 2.35085340 |
| 55 | Dysmetria (HP:0001310) | 2.34460842 |
| 56 | Thin bony cortex (HP:0002753) | 2.34379186 |
| 57 | Atonic seizures (HP:0010819) | 2.34166794 |
| 58 | Cellulitis (HP:0100658) | 2.33864891 |
| 59 | Gaze-evoked nystagmus (HP:0000640) | 2.33311028 |
| 60 | Genetic anticipation (HP:0003743) | 2.31373788 |
| 61 | Impaired smooth pursuit (HP:0007772) | 2.29737856 |
| 62 | Atrial fibrillation (HP:0005110) | 2.29728852 |
| 63 | Absence seizures (HP:0002121) | 2.29598451 |
| 64 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.29293875 |
| 65 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.29293875 |
| 66 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.29293875 |
| 67 | Status epilepticus (HP:0002133) | 2.26432257 |
| 68 | Febrile seizures (HP:0002373) | 2.26373876 |
| 69 | Muscle hypertrophy of the lower extremities (HP:0008968) | 2.24127555 |
| 70 | Macroorchidism (HP:0000053) | 2.23758126 |
| 71 | Heart block (HP:0012722) | 2.23041818 |
| 72 | Myotonia (HP:0002486) | 2.22246757 |
| 73 | Purpura (HP:0000979) | 2.22233662 |
| 74 | Ventricular arrhythmia (HP:0004308) | 2.21993524 |
| 75 | Scanning speech (HP:0002168) | 2.21946942 |
| 76 | Colitis (HP:0002583) | 2.21511026 |
| 77 | Primary atrial arrhythmia (HP:0001692) | 2.21428310 |
| 78 | Increased connective tissue (HP:0009025) | 2.20237403 |
| 79 | Ketoacidosis (HP:0001993) | 2.19346645 |
| 80 | Anxiety (HP:0000739) | 2.15226233 |
| 81 | Gingivitis (HP:0000230) | 2.14229043 |
| 82 | Myopathic facies (HP:0002058) | 2.13056574 |
| 83 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.12117360 |
| 84 | Abnormality of ocular smooth pursuit (HP:0000617) | 2.10934943 |
| 85 | Abnormal EKG (HP:0003115) | 2.09101053 |
| 86 | Stridor (HP:0010307) | 2.09012235 |
| 87 | Polygenic inheritance (HP:0010982) | 2.08885659 |
| 88 | Abnormality of macrophages (HP:0004311) | 2.08184969 |
| 89 | Torticollis (HP:0000473) | 2.07157257 |
| 90 | Deep venous thrombosis (HP:0002625) | 2.05985156 |
| 91 | Broad-based gait (HP:0002136) | 2.05883047 |
| 92 | Abnormal atrioventricular conduction (HP:0005150) | 2.04984005 |
| 93 | Atrioventricular block (HP:0001678) | 2.04830418 |
| 94 | Abnormality of the calf musculature (HP:0001430) | 2.03980801 |
| 95 | Lower limb amyotrophy (HP:0007210) | 2.03579124 |
| 96 | Vertebral compression fractures (HP:0002953) | 2.03431125 |
| 97 | Broad face (HP:0000283) | 2.03135292 |
| 98 | Supraventricular tachycardia (HP:0004755) | 2.02862476 |
| 99 | Ketosis (HP:0001946) | 2.02246790 |
| 100 | Neuronal loss in central nervous system (HP:0002529) | 2.02185838 |
| 101 | Insidious onset (HP:0003587) | 2.01407793 |
| 102 | Termporal pattern (HP:0011008) | 2.01407793 |
| 103 | Central scotoma (HP:0000603) | 2.00858707 |
| 104 | Ulnar bowing (HP:0003031) | 2.00417836 |
| 105 | Spastic gait (HP:0002064) | 2.00231441 |
| 106 | Hyperacusis (HP:0010780) | 2.00074709 |
| 107 | Gastrointestinal infarctions (HP:0005244) | 1.99896658 |
| 108 | Abnormality of skeletal muscle fiber size (HP:0012084) | 1.99868508 |
| 109 | Upper limb amyotrophy (HP:0009129) | 1.99742839 |
| 110 | Distal upper limb amyotrophy (HP:0007149) | 1.99742839 |
| 111 | Supraventricular arrhythmia (HP:0005115) | 1.98868796 |
| 112 | Increased variability in muscle fiber diameter (HP:0003557) | 1.98532899 |
| 113 | Flat acetabular roof (HP:0003180) | 1.98316558 |
| 114 | Hemiparesis (HP:0001269) | 1.98161993 |
| 115 | Distal lower limb amyotrophy (HP:0008944) | 1.98012281 |
| 116 | Increased IgE level (HP:0003212) | 1.97270899 |
| 117 | Dialeptic seizures (HP:0011146) | 1.96805236 |
| 118 | Cerebral inclusion bodies (HP:0100314) | 1.96491114 |
| 119 | Pheochromocytoma (HP:0002666) | 1.96272354 |
| 120 | Resting tremor (HP:0002322) | 1.95442778 |
| 121 | Aneurysm (HP:0002617) | 1.94753875 |
| 122 | Impaired vibratory sensation (HP:0002495) | 1.93930635 |
| 123 | Annular pancreas (HP:0001734) | 1.93192470 |
| 124 | Disproportionate tall stature (HP:0001519) | 1.93058543 |
| 125 | Pointed chin (HP:0000307) | 1.92802667 |
| 126 | Tetraplegia (HP:0002445) | 1.92790684 |
| 127 | EMG: neuropathic changes (HP:0003445) | 1.92483383 |
| 128 | Asymmetric septal hypertrophy (HP:0001670) | 1.91465224 |
| 129 | Myositis (HP:0100614) | 1.90583001 |
| 130 | Hypercholesterolemia (HP:0003124) | 1.90551778 |
| 131 | Recurrent abscess formation (HP:0002722) | 1.88997364 |
| 132 | Abnormality of the Achilles tendon (HP:0005109) | 1.88953749 |
| 133 | Broad metatarsal (HP:0001783) | 1.88916252 |
| 134 | Polycythemia (HP:0001901) | 1.88167606 |
| 135 | Amyloidosis (HP:0011034) | 1.88103149 |
| 136 | Prolonged partial thromboplastin time (HP:0003645) | 1.87543853 |
| 137 | Rapidly progressive (HP:0003678) | 1.86900082 |
| 138 | Abnormality of the common coagulation pathway (HP:0010990) | 1.86835315 |
| 139 | Abnormality of the fingertips (HP:0001211) | 1.86617739 |
| 140 | Elfin facies (HP:0004428) | 1.86117302 |
| 141 | Focal dystonia (HP:0004373) | 1.85972830 |
| 142 | Peritonitis (HP:0002586) | 1.85838490 |
| 143 | EMG: myopathic abnormalities (HP:0003458) | 1.85062444 |
| 144 | Onion bulb formation (HP:0003383) | 1.84837195 |
| 145 | Abnormality of saccadic eye movements (HP:0000570) | 1.84800370 |
| 146 | Achilles tendon contracture (HP:0001771) | 1.83676305 |
| 147 | Drooling (HP:0002307) | 1.83064240 |
| 148 | Excessive salivation (HP:0003781) | 1.83064240 |
| 149 | Loss of speech (HP:0002371) | 1.82729673 |
| 150 | Abnormality of the thoracic spine (HP:0100711) | 1.82709333 |
| 151 | Hamartoma of the eye (HP:0010568) | 1.82396763 |
| 152 | Neoplasm of the heart (HP:0100544) | 1.81437802 |
| 153 | Recurrent bacterial skin infections (HP:0005406) | 1.81198424 |
| 154 | Gingival bleeding (HP:0000225) | 1.81108444 |
| 155 | Ventricular tachycardia (HP:0004756) | 1.80182824 |
| 156 | Lower limb muscle weakness (HP:0007340) | 1.77854320 |
| 157 | Mitral regurgitation (HP:0001653) | 1.77712160 |
| 158 | Hypsarrhythmia (HP:0002521) | 1.77675638 |
| 159 | Cervical subluxation (HP:0003308) | 1.77230757 |
| 160 | Nephritis (HP:0000123) | 1.77155273 |
| 161 | Distal lower limb muscle weakness (HP:0009053) | 1.76851754 |
| 162 | Abnormal eating behavior (HP:0100738) | 1.76555306 |
| 163 | Myocardial infarction (HP:0001658) | 1.74304980 |
| 164 | Hypertriglyceridemia (HP:0002155) | 1.74146540 |
| 165 | Mitral stenosis (HP:0001718) | 1.73464860 |
| 166 | Thoracic kyphosis (HP:0002942) | 1.73292914 |
| 167 | Emphysema (HP:0002097) | 1.72762357 |
| 168 | Biconcave vertebral bodies (HP:0004586) | 1.72161962 |
| 169 | Reticulocytosis (HP:0001923) | 1.72130398 |
| 170 | Segmental peripheral demyelination/remyelination (HP:0003481) | 1.70706484 |
| 171 | Gastrointestinal inflammation (HP:0004386) | 1.68384864 |
| 172 | Obstructive lung disease (HP:0006536) | 1.68009020 |
| 173 | Chronic obstructive pulmonary disease (HP:0006510) | 1.68009020 |
| 174 | Turricephaly (HP:0000262) | 1.67689043 |
| 175 | Epistaxis (HP:0000421) | 1.66337772 |
| 176 | Increased cerebral lipofuscin (HP:0011813) | 1.66126423 |
| 177 | Hyperlipoproteinemia (HP:0010980) | 1.65882323 |
| 178 | Orchitis (HP:0100796) | 1.62913417 |
| 179 | Menorrhagia (HP:0000132) | 1.61620218 |
| 180 | Slow saccadic eye movements (HP:0000514) | 1.61401501 |
| 181 | Joint stiffness (HP:0001387) | 1.60828375 |
| 182 | Metaphyseal cupping (HP:0003021) | 1.59936449 |
| 183 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 1.59616335 |
| 184 | Meningitis (HP:0001287) | 1.59382881 |
| 185 | Increased serum ferritin (HP:0003281) | 1.59302987 |
| 186 | Hypercortisolism (HP:0001578) | 1.58754992 |
| 187 | Hand muscle atrophy (HP:0009130) | 1.58138518 |
| 188 | Abnormal gallbladder physiology (HP:0012438) | 1.57797788 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP3K9 | 3.09178884 |
| 2 | ERN1 | 2.98588174 |
| 3 | TRIB3 | 2.89729810 |
| 4 | NTRK3 | 2.83578480 |
| 5 | PRKD3 | 2.55125492 |
| 6 | EPHA4 | 2.46295048 |
| 7 | MAP3K4 | 2.40750821 |
| 8 | MARK1 | 2.33480932 |
| 9 | PHKG2 | 2.14003866 |
| 10 | PHKG1 | 2.14003866 |
| 11 | MAP2K3 | 2.13064531 |
| 12 | RIPK1 | 2.12794130 |
| 13 | PAK6 | 2.12416458 |
| 14 | DAPK2 | 2.03346535 |
| 15 | CAMKK1 | 2.00767615 |
| 16 | SMG1 | 1.92460390 |
| 17 | LMTK2 | 1.90387659 |
| 18 | MAP4K1 | 1.88856821 |
| 19 | KSR2 | 1.82606403 |
| 20 | PKN2 | 1.80377969 |
| 21 | MINK1 | 1.77227123 |
| 22 | CDK12 | 1.75491052 |
| 23 | NTRK2 | 1.70596198 |
| 24 | TTN | 1.67589451 |
| 25 | MAP3K11 | 1.65743396 |
| 26 | STK38 | 1.63617524 |
| 27 | MAP2K4 | 1.61500534 |
| 28 | BLK | 1.51503910 |
| 29 | CAMK1G | 1.48744629 |
| 30 | TYRO3 | 1.40026191 |
| 31 | NTRK1 | 1.39901697 |
| 32 | TYK2 | 1.35608129 |
| 33 | ICK | 1.35240047 |
| 34 | SIK2 | 1.34539254 |
| 35 | RET | 1.33427178 |
| 36 | PRKCH | 1.30566125 |
| 37 | PDK4 | 1.24838408 |
| 38 | PDK3 | 1.24838408 |
| 39 | KSR1 | 1.22281935 |
| 40 | MAP3K7 | 1.22197493 |
| 41 | PDGFRA | 1.21584684 |
| 42 | TAOK1 | 1.21148062 |
| 43 | IRAK3 | 1.20926835 |
| 44 | SIK1 | 1.20448407 |
| 45 | TNK2 | 1.19292392 |
| 46 | CDK5 | 1.17458561 |
| 47 | ZAP70 | 1.16699430 |
| 48 | DMPK | 1.15079886 |
| 49 | PRKD2 | 1.15036087 |
| 50 | EPHB1 | 1.13925126 |
| 51 | FGFR2 | 1.13609981 |
| 52 | MAP3K3 | 1.10561713 |
| 53 | TBK1 | 1.08021208 |
| 54 | NEK1 | 1.07622824 |
| 55 | SGK3 | 1.07531800 |
| 56 | MAP3K2 | 1.04240994 |
| 57 | CAMKK2 | 1.04114780 |
| 58 | PINK1 | 1.02017434 |
| 59 | PAK3 | 1.01793475 |
| 60 | TAOK2 | 1.01488412 |
| 61 | CAMK1D | 0.99054170 |
| 62 | GRK6 | 0.98121514 |
| 63 | MAP3K6 | 0.95035921 |
| 64 | EEF2K | 0.95008942 |
| 65 | CDC42BPA | 0.92358028 |
| 66 | WNK1 | 0.91721976 |
| 67 | STK11 | 0.90234369 |
| 68 | DYRK1B | 0.86626726 |
| 69 | MAP2K7 | 0.86600354 |
| 70 | PDK1 | 0.85813253 |
| 71 | CAMK1 | 0.85720584 |
| 72 | ALK | 0.85139727 |
| 73 | MAPK11 | 0.83950953 |
| 74 | PTK6 | 0.83768643 |
| 75 | SGK223 | 0.82967994 |
| 76 | SGK494 | 0.82967994 |
| 77 | CSK | 0.81904484 |
| 78 | JAK3 | 0.81869666 |
| 79 | MARK2 | 0.81178791 |
| 80 | UHMK1 | 0.81032853 |
| 81 | PDPK1 | 0.80730464 |
| 82 | RPS6KC1 | 0.78074133 |
| 83 | RPS6KL1 | 0.78074133 |
| 84 | SGK2 | 0.77888128 |
| 85 | OBSCN | 0.75144960 |
| 86 | FGFR4 | 0.74533132 |
| 87 | PRKAA1 | 0.74458607 |
| 88 | MTOR | 0.73988806 |
| 89 | CAMK4 | 0.73899359 |
| 90 | MAP3K10 | 0.73772611 |
| 91 | MAP3K14 | 0.73626549 |
| 92 | PRPF4B | 0.73411474 |
| 93 | PRKCG | 0.72711062 |
| 94 | IRAK4 | 0.70697509 |
| 95 | HCK | 0.67025105 |
| 96 | BTK | 0.66013536 |
| 97 | PTK2B | 0.65936035 |
| 98 | INSRR | 0.65715391 |
| 99 | PRKD1 | 0.65714019 |
| 100 | SGK1 | 0.65576833 |
| 101 | DDR2 | 0.65249473 |
| 102 | SCYL2 | 0.65102867 |
| 103 | ARAF | 0.64518328 |
| 104 | DAPK1 | 0.61279541 |
| 105 | LATS2 | 0.60502925 |
| 106 | MAPK12 | 0.59900713 |
| 107 | HIPK2 | 0.59856724 |
| 108 | RPS6KA3 | 0.59814315 |
| 109 | MAP3K1 | 0.58187916 |
| 110 | RPS6KA6 | 0.57532266 |
| 111 | IKBKE | 0.56128722 |
| 112 | JAK1 | 0.55824750 |
| 113 | SYK | 0.55382662 |
| 114 | BMX | 0.54758721 |
| 115 | ROCK1 | 0.53845027 |
| 116 | CSF1R | 0.53376419 |
| 117 | TESK2 | 0.52454399 |
| 118 | MAPK7 | 0.52376897 |
| 119 | RIPK4 | 0.52260211 |
| 120 | PRKCZ | 0.51991566 |
| 121 | FER | 0.51570897 |
| 122 | MAP3K13 | 0.51485350 |
| 123 | CDK15 | 0.51065611 |
| 124 | MAPK13 | 0.50613443 |
| 125 | FGR | 0.50521172 |
| 126 | MAPK15 | 0.50259497 |
| 127 | CAMK2A | 0.50215320 |
| 128 | CDK18 | 0.48452002 |
| 129 | ERBB2 | 0.48149763 |
| 130 | PDGFRB | 0.47461555 |
| 131 | IRAK2 | 0.46041888 |
| 132 | RPS6KA2 | 0.45980267 |
| 133 | TNIK | 0.45957479 |
| 134 | FYN | 0.45783317 |
| 135 | FGFR3 | 0.45483640 |
| 136 | MOS | 0.44014005 |
| 137 | PKN1 | 0.43695500 |
| 138 | FES | 0.43434197 |
| 139 | JAK2 | 0.42007708 |
| 140 | PRKACG | 0.40407784 |
| 141 | MAP2K2 | 0.40330861 |
| 142 | MAP2K6 | 0.39942227 |
| 143 | CDK4 | 0.39901135 |
| 144 | PTK2 | 0.39806971 |
| 145 | CDK11A | 0.39302887 |
| 146 | LCK | 0.39277363 |
| 147 | LRRK2 | 0.37797872 |
| 148 | PRKAA2 | 0.37545219 |
| 149 | MAPK4 | 0.36717615 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.02942202 |
| 2 | Other glycan degradation_Homo sapiens_hsa00511 | 2.83475069 |
| 3 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.30118402 |
| 4 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.11716508 |
| 5 | Nicotine addiction_Homo sapiens_hsa05033 | 1.89655420 |
| 6 | Circadian entrainment_Homo sapiens_hsa04713 | 1.89326571 |
| 7 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.88393968 |
| 8 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.86074386 |
| 9 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 1.82287513 |
| 10 | Long-term potentiation_Homo sapiens_hsa04720 | 1.81046122 |
| 11 | GABAergic synapse_Homo sapiens_hsa04727 | 1.76756354 |
| 12 | Olfactory transduction_Homo sapiens_hsa04740 | 1.74454164 |
| 13 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.73742089 |
| 14 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.69671442 |
| 15 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.69441529 |
| 16 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.67880005 |
| 17 | Insulin secretion_Homo sapiens_hsa04911 | 1.67801896 |
| 18 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.65640998 |
| 19 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.60338377 |
| 20 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.59301799 |
| 21 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.57997399 |
| 22 | Salivary secretion_Homo sapiens_hsa04970 | 1.56715570 |
| 23 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.55936952 |
| 24 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.55786779 |
| 25 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 1.55561957 |
| 26 | Morphine addiction_Homo sapiens_hsa05032 | 1.55221802 |
| 27 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.54861701 |
| 28 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.52721057 |
| 29 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.47492748 |
| 30 | Amphetamine addiction_Homo sapiens_hsa05031 | 1.41098052 |
| 31 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.40702061 |
| 32 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.39718294 |
| 33 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 1.38324160 |
| 34 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.36546017 |
| 35 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.36073019 |
| 36 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.35932122 |
| 37 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.34244667 |
| 38 | Bile secretion_Homo sapiens_hsa04976 | 1.34005584 |
| 39 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.33762083 |
| 40 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.32906910 |
| 41 | Renin secretion_Homo sapiens_hsa04924 | 1.28120879 |
| 42 | Notch signaling pathway_Homo sapiens_hsa04330 | 1.23945362 |
| 43 | Leishmaniasis_Homo sapiens_hsa05140 | 1.17656778 |
| 44 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.15841572 |
| 45 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.14808603 |
| 46 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.11701070 |
| 47 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.11672041 |
| 48 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.10657041 |
| 49 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.10379107 |
| 50 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.08548000 |
| 51 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.07790022 |
| 52 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.06965247 |
| 53 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.04922772 |
| 54 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 1.04810538 |
| 55 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 1.03355878 |
| 56 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 1.02769399 |
| 57 | cAMP signaling pathway_Homo sapiens_hsa04024 | 1.01782866 |
| 58 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.01459274 |
| 59 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.01295320 |
| 60 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.00154887 |
| 61 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.99707748 |
| 62 | Pertussis_Homo sapiens_hsa05133 | 0.98021826 |
| 63 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.97932433 |
| 64 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.97565770 |
| 65 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.97330824 |
| 66 | Glioma_Homo sapiens_hsa05214 | 0.97137401 |
| 67 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.97077927 |
| 68 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.96666809 |
| 69 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.96653350 |
| 70 | Gap junction_Homo sapiens_hsa04540 | 0.95968167 |
| 71 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.95918474 |
| 72 | Long-term depression_Homo sapiens_hsa04730 | 0.95094622 |
| 73 | Taste transduction_Homo sapiens_hsa04742 | 0.94940187 |
| 74 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.94036218 |
| 75 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.93787560 |
| 76 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.93625412 |
| 77 | Cocaine addiction_Homo sapiens_hsa05030 | 0.92285561 |
| 78 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.90776052 |
| 79 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.90111953 |
| 80 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.88703824 |
| 81 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.88624963 |
| 82 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.88021842 |
| 83 | Tuberculosis_Homo sapiens_hsa05152 | 0.88013027 |
| 84 | Insulin resistance_Homo sapiens_hsa04931 | 0.87906772 |
| 85 | Lysosome_Homo sapiens_hsa04142 | 0.87759789 |
| 86 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.87693130 |
| 87 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.86790084 |
| 88 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.86118102 |
| 89 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.86060294 |
| 90 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.85477743 |
| 91 | Hepatitis C_Homo sapiens_hsa05160 | 0.85138470 |
| 92 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.82591816 |
| 93 | Amoebiasis_Homo sapiens_hsa05146 | 0.82192870 |
| 94 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.81787017 |
| 95 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.81743634 |
| 96 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.80724598 |
| 97 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.80067996 |
| 98 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.79068833 |
| 99 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.76629764 |
| 100 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.75526227 |
| 101 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.74577061 |
| 102 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.73298889 |
| 103 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.72803351 |
| 104 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.71167467 |
| 105 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.71151892 |
| 106 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.71082903 |
| 107 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.70266392 |
| 108 | Platelet activation_Homo sapiens_hsa04611 | 0.69770007 |
| 109 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.69448055 |
| 110 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.69281833 |
| 111 | Bladder cancer_Homo sapiens_hsa05219 | 0.69088650 |
| 112 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.67865164 |
| 113 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.65597322 |
| 114 | Focal adhesion_Homo sapiens_hsa04510 | 0.64818054 |
| 115 | Lysine degradation_Homo sapiens_hsa00310 | 0.64675633 |
| 116 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.64333437 |
| 117 | Influenza A_Homo sapiens_hsa05164 | 0.63630277 |
| 118 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.63007689 |
| 119 | Hepatitis B_Homo sapiens_hsa05161 | 0.62240923 |
| 120 | Melanogenesis_Homo sapiens_hsa04916 | 0.61856384 |
| 121 | Axon guidance_Homo sapiens_hsa04360 | 0.60174681 |
| 122 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.59807788 |
| 123 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.59065754 |
| 124 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.58341408 |
| 125 | Galactose metabolism_Homo sapiens_hsa00052 | 0.58136885 |
| 126 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.57117928 |
| 127 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.56608000 |
| 128 | Endometrial cancer_Homo sapiens_hsa05213 | 0.56219273 |
| 129 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.55739959 |
| 130 | Carbon metabolism_Homo sapiens_hsa01200 | 0.54978516 |
| 131 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.54732584 |
| 132 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.53908715 |
| 133 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.53592993 |
| 134 | Malaria_Homo sapiens_hsa05144 | 0.53436958 |
| 135 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.52421439 |
| 136 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.51957049 |
| 137 | Salmonella infection_Homo sapiens_hsa05132 | 0.51922625 |
| 138 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.51342186 |
| 139 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.51141504 |
| 140 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.50875002 |
| 141 | ABC transporters_Homo sapiens_hsa02010 | 0.50390528 |
| 142 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.50251572 |
| 143 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.49577392 |
| 144 | Apoptosis_Homo sapiens_hsa04210 | 0.49416056 |
| 145 | Circadian rhythm_Homo sapiens_hsa04710 | 0.48583648 |
| 146 | Colorectal cancer_Homo sapiens_hsa05210 | 0.48206124 |
| 147 | Measles_Homo sapiens_hsa05162 | 0.45641422 |
| 148 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.45228852 |
| 149 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.44646197 |
| 150 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.43978178 |
| 151 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.42565998 |
| 152 | Prion diseases_Homo sapiens_hsa05020 | 0.42383111 |
| 153 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.40948207 |
| 154 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.39493119 |
| 155 | Endocytosis_Homo sapiens_hsa04144 | 0.39302163 |

